Chair: Hiddo Lambers Heerspink (NLD)
| 15:30 – 15:35 | Chair welcome and introductions | Hiddo Lambers Heerspink (NLD) |
| 15:35 – 15:55 | Cellular energetics and the positive impact of SGLT2 inhibition | Esther Phielix (NLD) |
| 15:55 – 16:15 | The science supporting SGLT2 inhibitors renal benefits | Hiddo Lambers Heerspink (NLD) |
| 16:15 – 16:35 | The underlying mechanisms of SGLT2 inhibitors across the ejection fraction spectrum | Kieran Docherty (UK) |
| 16:35 – 16:55 | SGLT2 inhibitors: Where do we go from here? | All faculty |
| 16:55 – 17:00 | Summary and close | Hiddo Lambers Heerspink (NLD) |
Disclaimer: This non-promotional symposium is organized and funded by AstraZeneca for healthcare professionals only.
- 2 October 2023
- 15:30 - 17:00 CEST
- Seoul Hall
